Takeda Pharmaceutical Company Limited
MATRIX COMPOSITION

Last updated:

Abstract:

The present invention provides means for producing an organoid close to an organ in a living body and capable of secretion of a plasma protein and immune response. A matrix composition of the present invention provided as such means includes: (1) a first matrix containing one or more cells selected from the group consisting of vascular cells, nerve cells, and blood cells; and (2) a second matrix containing to cells constituting an organ and/or an organoid, in which the first matrix envelops the second matrix, and the first matrix has at least one opening.

Status:
Application
Type:

Utility

Filling date:

27 Mar 2020

Issue date:

23 Jun 2022